
| Phytochemical Name | Atractylenolide-III |
| PubChem CID | 155948 |
| Disease Indication | Sepsis [ICD-11: 1G40] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Docetaxel |
| Source |
Warm
Atractylodes macrocephala
|
| Phytochemical Name | Atractylenolide I |
| PubChem CID | 5321018 |
| Disease Indication | Intestinal adenoma [ICD-11: 2E92] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Cabozantinib; Erlotinib |
| Source |
Warm
Atractylodes macrocephala;
Atractylodes lancea
Even
Poria cocos;
Poria cocos;
|
| Phytochemical Name | Atractylenolide-III |
| PubChem CID | 155948 |
| Disease Indication | Sepsis [ICD-11: 1G40] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Docetaxel |
| Source |
Warm
Atractylodes macrocephala
|
| Phytochemical Name | Atractylenolide I |
| PubChem CID | 5321018 |
| Disease Indication | Intestinal adenoma [ICD-11: 2E92] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Cabozantinib; Erlotinib |
| Source |
Warm
Atractylodes macrocephala;
Atractylodes lancea
Even
Poria cocos;
Poria cocos;
|
| Phytochemical Name | Atractylenolide-III |
| PubChem CID | 155948 |
| Disease Indication | Sepsis [ICD-11: 1G40] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Docetaxel |
| Source |
Warm
Atractylodes macrocephala
|
| Phytochemical Name | Atractylenolide I |
| PubChem CID | 5321018 |
| Disease Indication | Intestinal adenoma [ICD-11: 2E92] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Cabozantinib; Erlotinib |
| Source |
Warm
Atractylodes macrocephala;
Atractylodes lancea
Even
Poria cocos;
Poria cocos;
|